122 related articles for article (PubMed ID: 30592780)
1. Upper GI biopsies for adenocarcinoma - how many biopsies should endoscopists take?
Kaye P; Lindsay D; Madhusudan S; Vohra R; Catton J; Platt C; Ragunath K
Histopathology; 2019 May; 74(6):959-963. PubMed ID: 30592780
[TBL] [Abstract][Full Text] [Related]
2. HER2 testing in advanced gastric and gastro-oesophageal cancer: analysis of an Australia-wide testing program.
Kumarasinghe MP; Morey A; Bilous M; Farshid G; Francis G; Lampe G; McCue G; Von Neumann-Cosel V; Fox SB
Pathology; 2017 Oct; 49(6):575-581. PubMed ID: 28823752
[TBL] [Abstract][Full Text] [Related]
3. Digital image analysis of HER2 immunohistochemistry in gastric- and oesophageal adenocarcinoma: a validation study on biopsies and surgical specimens.
Koopman T; de Bock GH; Buikema HJ; Smits MM; Louwen M; Hage M; Imholz ALT; van der Vegt B
Histopathology; 2018 Jan; 72(2):191-200. PubMed ID: 28746978
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic findings in a mass screening program for gastric cancer in a high risk region - Guilan province of Iran.
Mansour-Ghanaei F; Sokhanvar H; Joukar F; Shafaghi A; Yousefi-Mashhour M; Valeshabad AK; Fakhrieh S; Aminian K; Ghorbani K; Taherzadeh Z; Sheykhian MR; Rajpout Y; Mehrvarz A
Asian Pac J Cancer Prev; 2012; 13(4):1407-12. PubMed ID: 22799340
[TBL] [Abstract][Full Text] [Related]
5. Missed diagnoses in patients with upper gastrointestinal cancers.
Yalamarthi S; Witherspoon P; McCole D; Auld CD
Endoscopy; 2004 Oct; 36(10):874-9. PubMed ID: 15452783
[TBL] [Abstract][Full Text] [Related]
6. Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy.
Borovicka J; Fischer J; Neuweiler J; Netzer P; Gschossmann J; Ehmann T; Bauerfeind P; Dorta G; Zürcher U; Binek J; Meyenberger C
Endoscopy; 2006 Sep; 38(9):867-72. PubMed ID: 16981102
[TBL] [Abstract][Full Text] [Related]
7. HER2 Heterogeneity in Gastroesophageal Cancer Detected by Testing Biopsy and Resection Specimens.
Fazlollahi L; Remotti HE; Iuga A; Yang HM; Lagana SM; Sepulveda AR
Arch Pathol Lab Med; 2018 Apr; 142(4):516-522. PubMed ID: 28782986
[TBL] [Abstract][Full Text] [Related]
8. Matched biopsy and resection specimens of gastric and gastroesophageal adenocarcinoma show high concordance in HER2 status.
Wang T; Hsieh ET; Henry P; Hanna W; Streutker CJ; Grin A
Hum Pathol; 2014 May; 45(5):970-5. PubMed ID: 24656529
[TBL] [Abstract][Full Text] [Related]
9. HER2 testing in gastric and gastroesophageal adenocarcinomas.
Vakiani E
Adv Anat Pathol; 2015 May; 22(3):194-201. PubMed ID: 25844677
[TBL] [Abstract][Full Text] [Related]
10. Dual-colour HER2/chromosome 17 chromogenic in situ hybridisation assay enables accurate assessment of HER2 genomic status in gastric cancer and has potential utility in HER2 testing of biopsy samples.
Yan B; Yau EX; Choo SN; Ong CW; Yong KJ; Pang B; Salto-Tellez M
J Clin Pathol; 2011 Oct; 64(10):880-3. PubMed ID: 21757431
[TBL] [Abstract][Full Text] [Related]
11. Cytokeratin phenotyping does not help in distinguishing oesophageal adenocarcinoma from cancer of the gastric cardia.
van Lier MG; Bomhof FJ; Leendertse I; Flens M; Balk AT; Loffeld RJ
J Clin Pathol; 2005 Jul; 58(7):722-4. PubMed ID: 15976339
[TBL] [Abstract][Full Text] [Related]
12. Ideal number of biopsy tumor fragments for predicting HER2 status in gastric carcinoma resection specimens.
Ahn S; Ahn S; Van Vrancken M; Lee M; Ha SY; Lee H; Min BH; Lee JH; Kim JJ; Choi S; Jung SH; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kim KM
Oncotarget; 2015 Nov; 6(35):38372-80. PubMed ID: 26460823
[TBL] [Abstract][Full Text] [Related]
13. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
Mortensen MB
Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
[TBL] [Abstract][Full Text] [Related]
14. How many endoscopic biopsy specimens?
Rowland R; Durbridge T
Med J Aust; 1976 Jul; 2(5):172-3. PubMed ID: 979835
[TBL] [Abstract][Full Text] [Related]
15. MALDI profiles of proteins and lipids for the rapid characterisation of upper GI-tract cancers.
Singhal R; Carrigan JB; Wei W; Taniere P; Hejmadi RK; Forde C; Ludwig C; Bunch J; Griffiths RL; Johnson PJ; Tucker O; Alderson D; Günther UL; Ward DG
J Proteomics; 2013 Mar; 80():207-15. PubMed ID: 23376328
[TBL] [Abstract][Full Text] [Related]
16. Human epidermal growth factor receptor 2 testing in gastric carcinoma: issues related to heterogeneity in biopsies and resections.
Lee S; de Boer WB; Fermoyle S; Platten M; Kumarasinghe MP
Histopathology; 2011 Nov; 59(5):832-40. PubMed ID: 22092394
[TBL] [Abstract][Full Text] [Related]
17. The utility of cytokeratin subsets in distinguishing Barrett's-related oesophageal adenocarcinoma from gastric adenocarcinoma.
Ormsby AH; Goldblum JR; Rice TW; Richter JE; Gramlich TL
Histopathology; 2001 Apr; 38(4):307-11. PubMed ID: 11318895
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic brush cytology and biopsy in the diagnosis of cancer of the upper gastrointestinal tract.
Qizilbash AH; Castelli M; Kowalski MA; Churly A
Acta Cytol; 1980; 24(4):313-8. PubMed ID: 6932143
[TBL] [Abstract][Full Text] [Related]
19. Image cytometric HER2 in gastric carcinoma: is a new algorithm needed?
Ormenisan C; Wang J; Lawson D; Cohen C
Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):414-9. PubMed ID: 23197004
[TBL] [Abstract][Full Text] [Related]
20. Gastric adenocarcinoma on incidental upper GI endoscopy.
Akabah P; Mocan S; Dobru D
J Gastrointestin Liver Dis; 2016 Jun; 25(2):136. PubMed ID: 27308641
[No Abstract] [Full Text] [Related]
[Next] [New Search]
